ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 159631 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 159631; 2) Community: the network communities that were significantly associated with the response to NSC 159631; 3) Molecule: the relationships between components within communities and NSC 159631; 4) MDR: the compounds that were significantly associated with the NSC 159631.

NSC Compound Enrichment Correlation
NSC 669888 Null 0.0459335986102865 0.34183022
NSC 670765 Null 0.0459335986102865 0.21173673
NSC 671392 Null 0.0459335986102865 0.338002
NSC 677275 Null 0.0459335986102865 0.15929017
NSC 677598 Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer 0.0459335986102865 0.23239212
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0459335986102865 0.073982204
NSC 679800 Null 0.0459335986102865 0.071465774
NSC 681239 Bortezomib 0.0459335986102865 0.11671061
NSC 681968 Benzoic acid, [[2-methyl-4-[bis(2-cyanoethyl)amino]phenyl]methylene] hydrazide 0.0459335986102865 0.2581517
NSC 690270 ANTINEOPLASTIC-690270 0.0459335986102865 0.35048618
Total:136  Current:121    [First] [Prev] [Next] [Last]